Final Results Of A Phase 3 Study Of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil In Chemoradiotherapy For Locally Advanced Esophageal Carcinoma (Eso-Shanghai 1).

Yun Chen,Kuaile Zhao,Jingjun Ye,Zhengfei Zhu,Weixin Zhao,Ling Li,Jialiang Zhou,Chaoyang Wu,Huarong Tang,Gang Xu,Q. Lin,Jiancheng Li,Yi Xia,Yunhai Li,Zhen Zhang

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 0|浏览15

暂无评分

摘要

4053Background: Concurrent chemoradiotherapy (CCR) with cisplatin plus 5-Fu (PF) regimen is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. This trial a...

查看译文

关键词

advanced esophageal carcinoma,chemoradiotherapy,paclitaxel,cisplatin,eso-shanghai

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要